BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's ...

Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes, to the consumer level. This recall ...

The company has launched Clobetasol Propionate ointment USP in the strength of 0.05 per cent. It had earlier received approval for the product from the United States Food and Drug Administration ...

Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Clobetasol Propionate Ointment USP, 0.05 percent. At 12:42 hrs Cadila Healthcare was ...

Sub:- Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Ointment USP, 0.05% With reference to the subject mentioned above, kindly find attached media release which is ...

New Delhi, Mar 21: Glenmark Pharmaceuticals USA has received approval from the United States Food and Drug Administration (USFDA) for Clobetasol Propionate Ointment, used for treatment of various skin ...

Lupin’s Clobetasol Propionate Cream USP 0.05% is the generic equivalent of Fougera Pharmaceuticals Inc’s Temovate Cream, 0.05%. It is a super-high potency corticosteroid indicated for the relief of ...

(RTTNews) - Taro Pharmaceuticals U.S.A., Inc. has recalled one lot of corticosteroid Clobetasol Propionate in the form of ointment for the potential presence of Ralstonia pickettii bacteria, the U.S.

According to IQVIA , Clobetasol Propionate ointment USP, 0.05 per cent, has an estimated market size of USD 63 million for twelve months ending December 2018, Alembic Pharmaceuticals said. Alembic ...

BUENA, N.J., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...

Drug firm Lupin Tuesday said it has launched generic Clobetasol Propionate ointment used for treatment of inflammation and itching caused by a number of skin conditions in the US market. The company ...